MedTrace Logo

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

NCT07155057 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-09-29

No results posted yet for this study

Summary

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Conditions

  • Dry Eye Disease (DED)

Interventions

DEVICE

Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

Prospective, single-site, single-arm study enrolling 60 patients who have elected advanced IOL implantation at the time of cataract surgery and have a diagnosis of dry eye disease. The study will consist of 5 study visits, over a 3-5 month time period. Patients will receive bilateral lacrimal occlusion of crosslinked hyaluronate canalicular gel pre-operatively

Sponsors & Collaborators

  • Vance Thompson Vision

    lead OTHER

Principal Investigators

  • Kayla Karpuk, OD · Vance Thompson Vision Clinic Prof. LLC

  • Vance Thompson, MD · Vance Thompson Vision Clinic Prof. LLC

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-03
Primary Completion
2026-06-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07155057 on ClinicalTrials.gov